SCHEMBL4908245

SCHEMBL4908245

CCN(c1ccc(-c2cccc3ccccc23)cc1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.46
LMNA P02545 3/20 0.44
ESR1 P03372 2/20 0.44
PKM P14618 2/20 0.42
ALDH1A1 P00352 4/20 0.42
HPGD P15428 2/20 0.42
HSD17B10 Q99714 2/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
ATM Q13315 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
MAPT P10636 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4900812 0.89 LMNA (0.54) LMNAESR1ALDH1A1HPGDHSD17B10
SCHEMBL4908510 0.84 ALDH1A1 (0.46) LMNAESR1PKMALDH1A1HPGD
SCHEMBL4905784 0.83 LMNA (0.47) LMNAESR1ALDH1A1HPGDHSD17B10
SCHEMBL4905482 0.83 NPSR1 (0.51) TP53LMNAESR1PKMALDH1A1
SCHEMBL4906761 0.83 ALDH1A1 (0.48) TP53LMNAESR1PKMALDH1A1
SCHEMBL4902995 0.82 HCRTR2 (0.47) TP53LMNAESR1PKMALDH1A1
SCHEMBL4905926 0.82 LMNA (0.49) TP53LMNAESR1ALDH1A1HPGD
SCHEMBL4899320 0.81 ALDH1A1 (0.52) TP53LMNAESR1ALDH1A1HPGD
SCHEMBL4898279 0.81 MAPT (0.51) TP53LMNAESR1ALDH1A1TSHR
SCHEMBL4904034 0.81 LMNA (0.50) TP53LMNAESR1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD TP53 3421/4885LMNA 319/4885ESR1 585/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD TP53 3421/4885LMNA 319/4885ESR1 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.